
Insights on Innovation, R&D, and IP
Perspectives on patents, scientific research, emerging technologies, and the strategies shaping modern R&D

Michael Devon, a retired Research Fellow who spent 34 years at Dow tested three AI systems against complex, known-answer R&D scenarios. The largest performance gap appeared where technical depth, IP interpretation and roadmap development mattered most.
General-purpose AI tools such as Microsoft Copilot and Claude Opus 5 are built primarily around frontier foundation models and broad-access knowledge. Cypris can use the same class of foundation models, but grounds them in focused scientific and intellectual property datasets connected through domain-specific ontologies.
This comparison was designed to test whether that additional intelligence layer materially changes the quality of technical research.
Michael Devon, a retired Research Fellow who spent 34 years at Dow, evaluated Cypris, Microsoft Copilot and Claude Opus 5 across two technical scenarios and four prompts. He deliberately chose areas he knew intimately, allowing him to distinguish a plausible summary from an analysis that captured the technical realities, historical context and commercial considerations required to build an R&D strategy.
The scenarios were representative of projects that historically required weeks of coordinated researcher effort. The objective was not simply to determine which tool could find relevant information. It was to determine which could transform that information into useful technical and strategic guidance rooted in real world context.
Evaluation design
The comparison covered two technology landscapes: hollow latex particle opacifiers and the use of hydroxypropyl methylcellulose, or HPMC, in osmotic drug-delivery systems. The outputs were evaluated based on result quality, strategic insight, accuracy and the ability to recognize the boundaries between related technologies.

The hollow particle prompts asked the systems to map the competitive and IP landscape, identify emerging participants in Mexico and Asia, detect licensing or corporate activity and locate white space. They were then asked to recommend alternative materials, particle architectures and manufacturing mechanisms that could support a defensible product strategy.
The osmotic delivery prompts asked the systems to identify manufacturers and marketed products, followed by an analysis of HPMC grades, viscosity specifications, processing methods, prior art and potential formulation strategies.
Where the tools diverged
All three tools were capable of producing a credible general summary. The meaningful differences appeared as the work moved from describing the landscape to deciding what to do next.

Devon found that Cypris produced the strongest overall result, with the clearest advantage in the more technically and strategically complex hollow particle scenario. Claude and Copilot generally summarized what had been published. Cypris more frequently identified the specific technical issues, changes in IP ownership, commercial signals and research directions that could influence an actual development program.
Comparative findings at a glance


These distinctions were particularly visible in Devon's analysis of technical implementation, IP transfers, market context and research direction.
Scenario One: Hollow Latex Particle Opacifiers
All three tools passed the baseline test
Each system produced a reasonable summary of the general hollow particle landscape. Devon found no serious factual errors within the information each tool chose to present.
That baseline performance was important, but it did not determine the outcome. The systems differed substantially in the usefulness of their output for technical strategy development, with Cypris holding the clear advantage.
Cypris identified the technical issue most likely to derail a new entrant
One of the most consequential differences involved particle collapse.
Cypris recognized that maintaining particle structure was a central technical challenge and produced a useful explanation of the issue. Claude and Copilot did not identify its importance.
For a researcher, this was not a minor omission. A new entrant that fails to understand or overcome particle collapse could invest considerable time and capital in a manufacturing approach that does not perform under practical conditions. By surfacing the issue, Cypris provided information that could directly alter experimental priorities and development sequencing.
Cypris was not flawless. It did not fully distinguish between Dow's hollow latex work using caustic expansion and a separate abandoned macroporous latex approach. However, Claude and Copilot missed the macroporous work entirely.
The distinction illustrates the difference between partial technical interpretation and simple omission. Cypris found the relevant body of work but needed greater precision in separating the approaches. The general AI tools failed to surface the alternative development path at all.
Cypris produced a stronger picture of the IP landscape
Patent landscapes are often presented as lists of companies, filings and portfolio sizes. For technology strategy, that is rarely sufficient.
Researchers need to understand whether patents remain active and relevant, whether they have been transferred, whether the underlying technology is commercially practiced and whether a seemingly large portfolio contains meaningful gaps.
Claude and Copilot missed technology transfers between companies. Devon also found that Claude failed to recognize that significant portions of the IP landscape had changed hands or become outdated. These omissions can distort the competitive picture by assigning technology to the wrong owner or treating historically important patents as if they still define the current opportunity.
Cypris provided a more useful view of how the IP was structured and where potential white space existed. This helped move the analysis beyond a patent count and toward questions such as:
- Who currently controls the relevant technology?
- Which patents still create meaningful barriers?
- Where has ownership changed?
- Which approaches appear abandoned or underdeveloped?
- Where could a new entrant build, partner or acquire?
Devon noted that all three tools could be improved by incorporating deeper patent-office and file-wrapper information, maintenance status, litigation history and citation patterns. Those signals help determine whether a portfolio is genuinely defensible or simply appears strong based on volume.
Cypris surfaced technical and commercial concepts the others missed
Cypris was the only tool to identify the use of hollow particles in thermal printing. It also suggested additional markets and alternative applications.
That finding demonstrated a broader advantage in state-of-the-art analysis. Cypris did not restrict the output to the most obvious use of hollow particles as opacifiers. It connected the underlying technology to another commercially relevant application that Claude and Copilot failed to identify.
The distinction matters because technical strategy requires answering two different questions:
- Can the organization develop the technology?
- Is the opportunity commercially worth pursuing?
Claude and Copilot largely addressed the first question through general technical summaries. Cypris brought in more of the information required to begin addressing the second.
Some commercial outputs still required scrutiny. Devon considered Cypris' estimated 10 percent compound annual growth rate for the broader hollow particle market questionable, although its approximately 5 percent estimate for the thermal-printing segment appeared reasonable. The advantage was not that every market figure was definitive. It was that Cypris recognized adjacent commercial applications and incorporated them into the strategic analysis at all.
Cypris produced more useful white-space and roadmap recommendations
Both Cypris and Claude suggested alternatives to conventional latex-based particle systems. Copilot's recommendations were less insightful.
The quality of the alternatives, however, was different. Claude's output was more general and matter-of-fact. It identified possible approaches but did not translate them into strong white-space guidance.
Cypris proposed more technically credible alternatives and connected them more directly to a differentiated development strategy. Its roadmap recommendations were clearer about which directions merited further investigation and how the research could be sequenced.
The alternatives included non-latex and ceramic-based particle systems. The evaluation did not establish that every proposed direction was commercially viable, but Devon knew that some ceramic particles had progressed at least as far as commercial trials. Cypris therefore surfaced technically relevant research leads rather than merely generating hypothetical possibilities.
Specific findings that changed the strategic value of the output

Scenario Two: HPMC in Osmotic Drug Delivery
The baseline outputs were more similar
The osmotic drug-delivery scenario produced less separation between the three systems.
All three generated credible summaries of osmotic pump technology and identified, to varying degrees, the grades and functions of HPMC in the existing landscape. Devon found relatively little to distinguish the tools on the initial market, manufacturer and prior-art questions.
The systems also converged on a similar roadmap recommendation: use a Design of Experiments process to optimize HPMC for the different roles it plays in the formulation.
While technically valid, Devon considered that recommendation underwhelming. It represented a standard development methodology rather than a differentiated technical insight.
Cypris generated the most promising next research direction
The difference appeared when Cypris suggested a possible connection between osmotic delivery and the challenge of formulating poorly soluble drugs.
Many active pharmaceutical ingredients have limited aqueous solubility, creating substantial formulation and absorption challenges. Cypris' analysis pointed toward a possible connection with hydroxypropyl methylcellulose acetate succinate, or HPMCAS, a material used in approaches for poorly soluble drugs.
HPMCAS is distinct from the HPMC traditionally used in osmotic systems, and Cypris did not present the connection as a validated solution. Instead, it surfaced a cross-domain clue that an experienced researcher could recognize and investigate further.
Devon viewed this as a meaningful example of how technical research often progresses. The first search does not always deliver the final answer. A strong research system should also reveal the next productive question.
Cypris did that more effectively. It connected information from an adjacent technical area to the osmotic formulation problem, creating the basis for a more differentiated next prompt and potential research direction.
The Core Finding: Technical Intelligence Begins Where the Summary Ends
The comparison showed that general-purpose AI tools can produce useful technical summaries. Both Claude Opus 5 and Microsoft Copilot identified relevant companies, scientific concepts and prior art across the two scenarios.
Cypris separated itself in the work that followed:
- Recognizing a technical failure mode that could derail a development program
- Identifying ownership changes and outdated IP that altered the competitive landscape
- Finding adjacent applications such as thermal printing
- Producing more specific white-space guidance
- Connecting evidence to a clearer R&D roadmap
- Generating cross-domain clues that informed the next research question
This distinction reflects the role of the intelligence layer surrounding the foundation model. A general-purpose model is optimized to explain the available information coherently. A technical intelligence system must also organize patents, scientific literature, companies, materials and market signals into a structure that supports decisions.
Final assessment
Across the four prompts, Cypris produced the strongest overall performance.
The advantage was clearest in the hollow particle scenario, where Cypris demonstrated superior technical analysis, stronger IP intelligence, more credible white-space identification and more actionable roadmap recommendations. Claude Opus 5 was capable of producing credible summaries and some alternative ideas, but remained more general and missed important IP changes and white-space implications. Microsoft Copilot met the baseline requirement for landscape summarization but provided the least differentiated strategic guidance.
The osmotic delivery scenario was more competitive, but Cypris still produced the most promising next research direction by connecting the problem to an adjacent material and formulation challenge.
The conclusion was not simply that Cypris found more information. It more consistently identified the information that mattered.
For an experienced technical leader, that is the difference between receiving a summary of the landscape and receiving the raw material required to build a technology strategy.
Former Dow Research Fellow Compares Cypris, Copilot & Claude for Chemical Intelligence
All Blogs

Sodium-ion batteries have moved from laboratory alternative to commercial reality, and their patent landscape is distinctive because the field is consolidating around a few competing chemistries just as production scales. A sodium-ion cell works on the same intercalation principle as a lithium-ion cell but shuttles sodium ions instead of lithium, which trades lower energy density for real advantages: sodium is abundant and cheap, the cells are safer and perform better in the cold, and they avoid the constrained lithium and cobalt supply chains, making them attractive for grid storage and entry-level electric vehicles. The intellectual property divides across several regions, each a distinct area of patenting: the cathode, where three chemistries compete, layered transition-metal oxides, Prussian blue analogs, and polyanionic phosphates, each with different trade-offs in energy density, cost, and cycle life;⁵ the anode, dominated by hard carbon, whose disordered microstructure stores sodium through a combination of sloping and plateau capacity and whose reversible and irreversible capacity are set by that microstructure;¹,² the electrolyte; and the cell and manufacturing design, much of which can be adapted from existing lithium-ion production lines. Because a competitive cell depends on several of these layers, freedom-to-operate and white space analysis must span the cathode chemistries and the other layers together.
The landscape is concentrated and moving quickly. Commercial sodium-ion products have launched: CATL introduced a first-generation cell in 2021 and, in 2025, its higher-density Naxtra series, which the company reports reaches an energy density of about 175 watt-hours per kilogram, operates from roughly −40 to 70 degrees Celsius, and exceeds ten thousand cycles, positioning it close to lithium iron phosphate cells for entry-level vehicles.⁶ In early 2026, CATL and Changan announced what CATL describes as the first mass-production passenger vehicle powered by sodium-ion cells.⁷ Activity is heavily concentrated among a small number of large battery manufacturers pursuing full-stack portfolios that span cathode, anode, electrolyte, and manufacturing, with a broad tail of materials specialists and research institutes. This shows clearly in the patent record: across the Cypris corpus of more than 500 million patents and scientific papers, the sodium-ion set is the largest of any topic Cypris tracks in this area, on the order of 37,408 families, and grew from about 1,585 in 2020 to roughly 5,970 in 2024, with the most active assignees led by CATL and its recycling affiliate Brunp alongside research institutes such as the Institute of Physics of the Chinese Academy of Sciences and the Dalian Institute of Chemical Physics, and China overwhelmingly dominant on geography (about 24,235 families) ahead of the United States (about 1,931) and Japan (about 1,669); 2025 and 2026 counts are partial because of the publication lag.
The strategic question is which chemistry and layer to back, and the white space sits where performance and cost are hardest to reconcile. On the cathode side, raising energy density and cycle life while holding down cost is the central problem, and each of the three chemistries has open ground.⁵ On the anode side, hard carbon is the workhorse, but improving its initial coulombic efficiency, its capacity, and the cost and consistency of its precursors is a large, active opportunity, with precursor selection, such as phenolic-resin-derived carbons, itself a patentable lever, as are novel and anode-light or anode-free designs.¹,²,³,⁴ Electrolytes tuned for sodium and recycling processes adapted to sodium chemistry are further layers. Reading the landscape by chemistry, layer, and owner, and tracking both the patents and the underlying materials research, is what separates a crowded region from an open one.
Where the sodium-ion white space is
High-performance cathodes. Raising energy density and cycle life while holding down cost, across layered oxides, Prussian blue analogs, and polyanionic phosphates, is the central problem and each chemistry has open ground.⁵
Hard-carbon anode improvement. Improving initial coulombic efficiency, capacity, and low-cost, consistent precursors for hard carbon is a large, active layer.¹,²,³
Anode-light and anode-free designs. Cell designs that reduce or omit the anode active layer for higher energy density are an emerging, differentiating area.
Sodium-tuned electrolytes. Electrolytes and interphase chemistries optimized for sodium's larger ion are a distinct layer affecting performance and durability.
Sodium recycling. Recovery and recycling processes adapted to sodium-ion chemistry are an early layer that will matter as volumes grow.
How AI-powered landscape and white space analysis helps
Resolving a landscape that spans three cathode chemistries and several cell layers, concentrated among a few large filers, requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by chemistry and layer across varied terminology, attribution that normalizes filers to canonical entities and tracks new entrants, and continuous monitoring that keeps pace with a fast-scaling field. Because sodium-ion advances appear in scientific and materials literature before they are patented, reading both patents and literature gives the earliest signal of where durable, low-cost cells are emerging.
Where Cypris fits
Cypris runs patent landscape and white space analysis for fast-scaling energy fields such as sodium-ion batteries across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by cathode chemistry, layered oxide, Prussian blue analog, and polyanionic phosphate, and by layer, anode, electrolyte, cell, and manufacturing, and normalizes filers to canonical entities, so a team can resolve which chemistries and layers are crowded and which remain open as white space, and can track new entrants as the field scales. Semantic search across patents and scientific literature connects filings to the underlying materials research, which is where sodium-ion advances appear first. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined chemistry over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.
FAQ
What is the sodium-ion battery patent landscape? The sodium-ion battery patent landscape is the set of patents covering cells that store energy by shuttling sodium ions rather than lithium. It divides across three cathode chemistries, layered oxides, Prussian blue analogs, and polyanionic phosphates, plus the hard-carbon anode, electrolytes, and cell and manufacturing design. Each is a distinct region of patenting.
Why are sodium-ion batteries gaining ground? Sodium-ion batteries are gaining ground because sodium is abundant and cheap, the cells are safer and perform better in cold weather, and they avoid constrained lithium and cobalt supply chains. They trade lower energy density for these advantages, which suits grid storage and entry-level electric vehicles. Commercial launches have moved the technology from research to market.
What are the main sodium-ion cathode chemistries? The main cathode chemistries are layered transition-metal oxides, which offer higher energy density; Prussian blue analogs, which offer low cost; and polyanionic phosphates, which offer stability and long cycle life. Each carries different trade-offs and its own IP. The choice of chemistry shapes both the technical and the freedom-to-operate picture.
Where is the white space in sodium-ion batteries? The white space includes higher-performance cathodes across all three chemistries, hard-carbon anode improvement and low-cost precursors, anode-light and anode-free designs, sodium-tuned electrolytes, and sodium recycling. Activity is concentrated among a few large filers, leaving room in the materials and design layers. The central problem is reconciling energy density, cycle life, and cost.
Why is the hard-carbon anode a focus? The hard-carbon anode is a focus because it is the workhorse anode for sodium-ion cells, and its initial coulombic efficiency, capacity, and precursor cost and consistency are key determinants of cell performance and economics. Its disordered microstructure governs how much sodium it stores reversibly. Improving these, including through precursor selection, is an active, large layer of the landscape.
Why does sodium-ion analysis need scientific literature? Sodium-ion analysis needs scientific literature because cathode, anode, and electrolyte advances appear in materials research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.
What software helps analyze the sodium-ion battery patent landscape? Software for the sodium-ion landscape should cluster activity by cathode chemistry and cell layer, resolve filers to canonical owners, search patents and scientific literature semantically, and monitor a fast-scaling field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.
Which teams use sodium-ion patent landscape analysis? Sodium-ion patent landscape analysis is used by R&D, innovation, IP, and strategy teams at battery and materials makers, automotive and energy-storage companies, and their suppliers, as well as investors assessing the sector. It informs which chemistry and layer to back, where to file, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across energy, advanced materials, chemicals, and other regulated industries.
Endnotes
- Xu, Z., Guo, X., Xie, F., & Titirici, M.-M. (2020). Hard carbons for sodium-ion batteries and beyond. Progress in Energy, 2(4). https://doi.org/10.1088/2516-1083/aba5f5
- Irisarri, E., Ponrouch, A., & Palacín, M. R. (2015). Review — hard carbon negative electrode materials for sodium-ion batteries. Journal of the Electrochemical Society, 162(14). https://doi.org/10.1149/2.0091514jes
- Sagues, W. J., Park, S., et al. (2024). Phenolic-resin-derived hard carbon anode for sodium-ion batteries: a review. ACS Energy Letters, 9(6). https://doi.org/10.1021/acsenergylett.4c00688
- Sun, N., Peng, H., Liu, Z., et al. (2024). Recent progress in hard carbon anodes for sodium-ion batteries. Advanced Engineering Materials, 26(9). https://doi.org/10.1002/adem.202302063
- Zhu, X., He, Y., Liu, Y., & Wu, Y. (2024). Review of cathode materials for sodium-ion batteries. Progress in Solid State Chemistry, 74. https://doi.org/10.1016/j.progsolidstchem.2024.100452
- Contemporary Amperex Technology Co., Ltd. (2025). Naxtra battery breakthrough and dual-power architecture: CATL pioneers the multi-power era. https://www.catl.com/en/news/6401.html
- Contemporary Amperex Technology Co., Ltd. (2026). CATL and Changan launch the world's first mass-production sodium-ion passenger vehicle. https://www.catl.com/en/news/6720.html

Humanoid robotics has moved from research demonstrations toward commercialization, and its patent landscape is being staked out quickly and unevenly. A humanoid robot integrates several distinct technology layers, each independently patentable: the actuators and joints that produce motion, the perception and sensing systems that let the robot model its surroundings, the motion, balance, and whole-body control that keep it upright and coordinated, and the embodied-AI layer that connects high-level decision-making to physical action. Companies such as Tesla, Figure, and Unitree have pushed the field into a commercialization race, and peer-reviewed patent analyses of humanoid robotics describe a cross-disciplinary field whose filings span mechatronics, control, and perception and identify the subfields where activity concentrates.¹,²
The geographic story dominates the data. An analysis across the Cypris corpus of more than 500 million patents and scientific papers finds a humanoid- and bipedal-robotics family set in which China holds roughly two-thirds of all-time families, about 8,804, versus about 711 for the United States and about 407 for Japan. The concentration is sharper in recent years: over the 2020 to 2025 window, Chinese applicants account for roughly three-quarters of families, about 3,169, far ahead of the United States, about 142, and Japan, about 83, with 2025 counts partial because of the roughly eighteen-month publication lag. Research output tells a different story from filing volume: scientometric analysis of the humanoid-robotics literature finds the United States, Japan, and Germany leading publication output, a reminder that leadership in papers and leadership in patent volume do not always coincide, and that raw family counts measure filing activity rather than influence or quality.³
The timing is as striking as the geography. Across the Cypris corpus, humanoid- and bipedal-robotics filings in the 2020 to 2025 window were roughly flat through 2022, around 300 to 320 per year, before accelerating sharply, to about 387 in 2023, 857 in 2024, and 1,915 in 2025 on a partial count, indicating a shift from enabling technologies toward the physical embodiment and control of the robots themselves. The most active assignees in the set span regions and sectors: SoftBank's Aldebaran, China's UBTech, Honda, Boston Dynamics, Toyota, and Sony, alongside a broad tail of Chinese universities such as Zhejiang University, Harbin Institute of Technology (Shenzhen), and Tsinghua University, so incumbents anchor the established positions while a large university base drives Chinese breadth.
Policy priorities and the technical frontier shape where the landscape is heading. National industrial strategies have elevated robotics and embodied AI, and patent-graph analyses that link policy signals to filings map where those priorities are translating into intellectual property.⁹ The defining unsolved technical challenge, and therefore the most contested and most valuable IP frontier, is the integration of AI with motion control: end-to-end learning, embodied-AI and whole-body control models, and sim-to-real transfer that bridge high-level decision-making and low-level motion execution.⁴,⁵,⁶ Actuator design is a second critical layer, where torque density, backdrivability, and thermal performance for bipedal locomotion at production cost are the central problems, and where both electric and hydraulic actuation approaches remain under active development.⁷,⁸ Across the Cypris corpus, the actuator and joint layer is by far the most heavily patented, on the order of 8,000 families, followed by perception and sensing, around 4,100, motion and balance control, around 2,200, and the still-small but fastest-emerging embodied-AI and learning-based control layer, around 1,400. Because applications publish about eighteen months after filing, the 2024 to 2025 surge is under-represented, so the current frontier is more active than granted-patent counts suggest.
Where the humanoid-robotics white space is
Embodied-AI motion integration. Connecting learned high-level behavior to low-level motion control is the defining unsolved problem and the fastest-emerging, still comparatively small IP layer, leaving room for high-value positions.⁴
Actuator design. Torque density, backdrivability, and thermal performance for bipedal locomotion at production cost are central engineering problems and a heavily worked but still-advancing layer.⁷
Dexterous manipulation. Robust hands and fine manipulation remain difficult, and IP here is less crowded than locomotion.
Long-duration autonomy. Power, thermal management, and reliability for extended operation are enabling problems that gate deployment.
Cost-reduction engineering. Designs and processes that lower the cost of production-scale humanoids are a distinct and commercially decisive area.
How AI-powered landscape and white space analysis helps
Resolving a multi-layer, geographically lopsided, fast-accelerating landscape requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by layer, actuators, perception, control, and embodied AI, across varied terminology, attribution that normalizes corporate and university filers to canonical entities and captures the regional structure, and continuous monitoring that keeps pace with a surging field. Because humanoid-robotics advances appear in scientific literature before they are patented, and because research and patent leadership diverge here, reading both patents and literature gives the fullest and earliest signal of where the frontier is moving.
Where Cypris fits
Cypris runs patent landscape and white space analysis for fast-accelerating, multi-layer fields such as humanoid robotics across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by layer, actuators and joints, perception and sensing, motion and balance control, and embodied AI, and normalizes corporate and university filers to canonical entities, so a team can resolve which layers are crowded and which remain open as white space, and can see the regional structure clearly rather than as a flat list. Semantic search across patents and scientific literature connects filings to the underlying robotics and machine-learning research, which is where embodied-AI advances appear first, and where patent and research leadership diverge. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.
FAQ
How fast is humanoid-robotics patenting growing? Humanoid-robotics patenting is surging as companies race toward commercialization. An analysis of the Cypris corpus finds filings roughly flat through 2022 before accelerating sharply from 2023, rising from a few hundred per year to well over a thousand by 2025 on a partial count. The acceleration reflects a shift from enabling technologies toward the physical embodiment and control of the robots themselves.
Who leads in humanoid-robotics patents? China leads in humanoid-robotics patent volume, holding roughly two-thirds of all-time families and about three-quarters of families filed since 2020 in the Cypris corpus, well ahead of the United States and Japan. Research output tells a different story: scientometric analysis finds the United States, Japan, and Germany leading humanoid-robotics publications. Leadership in patents and in papers does not always coincide.
Why do patent counts and research output differ in humanoid robotics? Patent counts and research output differ because family counts measure filing volume, not scientific influence or patent quality, and the two can diverge. China leads on humanoid-robotics patent volume, while the United States, Japan, and Germany lead on publications. A full assessment therefore weighs filing volume against the underlying research rather than treating raw counts as a measure of value.
What are the main technology layers in humanoid robotics? The main layers are actuators and joints, perception and sensing, motion and balance control, and embodied AI that links decision-making to action. Each is independently patentable and often held by different owners. In the Cypris corpus the actuator layer is by far the most heavily patented, and embodied AI is the smallest but fastest-emerging.
What is the defining technical challenge in humanoid robotics? The defining technical challenge is integrating AI with motion control, connecting high-level, learned decision-making to low-level physical action through embodied-AI and whole-body control models and sim-to-real transfer. It is the most contested and most valuable IP frontier. It is also where the patent landscape is expanding fastest.
Where is the white space in humanoid robotics? The white space includes embodied-AI motion integration, actuator design for torque density and efficiency, dexterous manipulation, long-duration autonomy, and cost-reduction engineering for production-scale robots. Embodied-AI motion integration is the fastest-emerging and still comparatively small layer. Manipulation and autonomy are less crowded than locomotion.
Why does humanoid-robotics analysis need scientific literature? Humanoid-robotics analysis needs scientific literature because embodied-AI, control, and actuation advances appear in research before they are patented, and because patent and research leadership diverge in this field, so the literature gives the earliest and fullest signal. Analyzing patents alone gives a lagging and partial view. Cypris analyzes both across more than 500 million patents and scientific papers.
Which teams use humanoid-robotics patent landscape analysis? Humanoid-robotics patent landscape analysis is used by R&D, IP, and strategy teams at robotics companies, automotive and electronics firms, component and actuator suppliers, and universities, as well as investors assessing robotics assets. It informs which layer to back, where to file, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across research-intensive and regulated industries.
Endnotes
- Kumari, R., Lee, B.-H., Jeong, J. Y., Choi, K.-S., & Choi, K.-N. (2019). Topic modelling and social network analysis of publications and patents in humanoid robot technology. Journal of Information Science. https://doi.org/10.1177/0165551519887878
- Jang, D.-S., Park, S., Kim, G., Lee, J., & Kim, J. (2016). A hybrid method of analyzing patents for sustainable technology management in humanoid robot industry. Sustainability, 8(5), 474. https://doi.org/10.3390/su8050474
- Kumar, V., & Singh, K. (2026). Global research trends and thematic evolution in humanoid robotics: a scientometric and text mining study. Discover Artificial Intelligence. https://doi.org/10.1007/s44163-026-01251-x
- Wang, H. C., Chen, J., Zeng, W., Jin, X., & Yu, T. (2025). A survey of behavior foundation model: next-generation whole-body control system of humanoid robots. IEEE Transactions on Pattern Analysis and Machine Intelligence. https://doi.org/10.1109/tpami.2025.3649177
- Yuan, Y., & Zhao, W. (2025). Development of intelligent robots in the wave of embodied intelligence. National Science Review. https://doi.org/10.1093/nsr/nwaf159
- Humphreys, J., Zhou, C., Peng, T., & Bao, L. (2025). Deep reinforcement learning for robotic bipedal locomotion: a brief survey. Artificial Intelligence Review. https://doi.org/10.1007/s10462-025-11451-z
- Niiyama, R. (2022). Soft actuation and compliant mechanisms in humanoid robots. Current Robotics Reports. https://doi.org/10.1007/s43154-022-00084-7
- Faudzi, A. A. M., & Suzumori, K. (2018). Trends in hydraulic actuators and components in legged and tough robots: a review. Advanced Robotics. https://doi.org/10.1080/01691864.2018.1455606
- Zheng, Y. (2026). Discovering technology opportunities in humanoid robotics and embodied intelligence: a policy-semantic heterogeneous patent graph approach. Mendeley Data. https://doi.org/10.17632/hk63kt4swb

Anthropic released Claude Science on June 30, 2026, an AI workbench that brings the tools scientists use most into a single research environment. It coordinates specialist agents across genomics, proteomics, structural biology, and cheminformatics, connects to more than sixty scientific databases, manages compute from a laptop up to an HPC cluster, and produces auditable artifacts traced back to the exact code that made them. For an academic lab or a research group moving from raw data to a validated figure or a publication, it is a substantial step forward.
It is worth being clear about who that step forward is for. Claude Science is built for academic and research-lab science, and the way Anthropic introduced it makes that orientation plain. The early users it highlighted are a neuroscientist at the Allen Institute, an epidemiologist at UCSF, and a research-stage biotech. The workflow runs toward publication, with manuscripts and reproducible figures as the end products. It runs on a lab's own infrastructure, a laptop, a Linux box, or an HPC login node, and Anthropic is pairing the launch with a discounted Team plan for academic institutions and nonprofit research organizations, plus credits for academic AI-for-science projects. This is a tool designed around the academic research lifecycle, and it serves that lifecycle well.
Corporate R&D is a different setting with a different mandate, and the distinction matters for any enterprise team evaluating whether Claude Science fits how they actually work.
The academic lifecycle Claude Science is built around
Academic and research-lab work centers on the research loop itself: gathering data, running multistep analyses, validating results, and producing reproducible outputs that culminate in a paper. The early uses Anthropic highlighted show the shape of it. A neuroscientist compressed a long-form literature review from a two-year effort into a matter of weeks. An epidemiologist ran germline analyses in roughly one-tenth the time. A research biotech nominated experimental targets against criteria learned from its own data. The dataset is in hand, the question is defined, and the task is to run the analysis rigorously, reproducibly, and toward a publishable result. Claude Science accelerates exactly that.
Why corporate R&D operates on a different layer
Enterprise R&D does plenty of analytical work, but that work is bracketed by a question academic science rarely has to answer with the same stakes: which programs are worth resourcing at all, in a competitive market, this cycle. Which chemistries or platforms a competitor is building toward. Whether a promising internal direction is already crowded. What external signal suggests a market is about to move. A publication is not the goal; a defensible commercial bet is. And that judgment is not made inside a single dataset. It is made by reading the full external landscape continuously: patents, scientific literature, regulatory filings, clinical and trial registries, grant awards, M&A activity, hiring, and commercial launches, across the whole field and over time.
A chemical R&D example makes the gap concrete. Suppose a team is weighing a commitment to a new class of catalysts for sustainable polymers. The analytical part, modeling candidate structures, running reaction analyses, producing figures, is the kind of work an academic-oriented workbench does well. But the decisive questions sit outside it. Have competitors filed foundational work in this catalyst class recently. Did a national lab just publish the enabling chemistry that changes how crowded the space is. Is a regulatory shift in a target market about to reshape demand. An academic tool is not built to surface any of that, because academic science is not primarily organized around competitive positioning. Corporate R&D is.
The intelligence layer, and how it connects to the lab
Cypris is built for that layer. It is an R&D intelligence platform for corporate research and innovation teams, sitting on a corpus of more than 500 million patents and scientific papers organized by a proprietary R&D ontology, so teams can reason across a technology landscape rather than retrieve isolated documents. Cypris Q lets R&D teams interrogate that landscape in natural language, and Agentic Monitoring, launched in June 2026, continuously tracks patent offices, scientific literature, regulatory bodies, M&A activity, product launches, grant awards, and corporate news, surfacing emerging directions as the signals converge rather than waiting for a single keyword to trigger an alert.
The two tools serve different settings, but they are not mutually exclusive, and the connection point is worth understanding. An enterprise team that adopts Claude Science for its analytical strengths does not have to accept its academic blind spot as a given. Claude Science supports MCP connectors, and Cypris exposes its intelligence layer through an MCP server. That means the competitive and landscape context Cypris maintains can be connected into an agentic research environment like Claude Science via MCP, so an agent reasoning about a research problem can also draw on the external signal that tells it whether the problem aligns with where the field is moving. The lab-oriented workbench keeps its analytical speed; the intelligence layer supplies the commercial and competitive context it was never designed to hold.
For a corporate R&D organization, the takeaway is simple. Claude Science is an excellent tool for academic and research-lab science, built around a lifecycle that ends in publication. Enterprise R&D answers to a different mandate, deciding what work is worth doing in a competitive market, and an R&D intelligence platform like Cypris is built for that. Where teams use both, MCP lets the strategic layer and the analytical workbench operate together rather than apart.
FAQ
What is Claude Science?
Claude Science is an AI workbench for scientists, released by Anthropic on June 30, 2026. It integrates commonly used research tools and databases, coordinates specialist agents across domains like genomics, proteomics, structural biology, and cheminformatics, manages compute from a laptop to an HPC cluster, and produces reproducible, auditable artifacts including figures and manuscripts. It is available in beta for Pro, Max, Team, and Enterprise plans.
Who is Claude Science built for?
It is built for academic and research-lab science. Its workflow runs toward publication, it operates on a lab's own infrastructure, and Anthropic launched it with a discounted Team plan for academic institutions and nonprofit research organizations along with credits for academic AI-for-science projects. The early users it highlighted were academic and research-stage scientists.
Is Claude Science a fit for corporate R&D?
Its analytical capabilities are strong, but it is designed around the academic research lifecycle, which ends in publication rather than a competitive commercial decision. Corporate R&D operates on a different layer, deciding which programs are worth resourcing based on the external market and competitive landscape, that an academically oriented workbench is not built to address.
What is the difference between an AI workbench and an R&D intelligence platform?
An AI workbench like Claude Science accelerates analytical work inside a defined research problem, oriented toward reproducible, publishable results. An R&D intelligence platform like Cypris operates at the layer of deciding which problems and programs are worth pursuing commercially, by continuously reading the external landscape across patents, scientific literature, regulatory filings, M&A, grants, hiring, and commercial activity.
Why does the academic-versus-corporate distinction matter?
Academic science is organized around producing and validating new knowledge for publication. Corporate R&D is organized around making defensible commercial bets in a competitive market. The analytical work can look similar, but the surrounding decisions, and the external context required to make them, are fundamentally different.
How does this apply to chemical R&D?
A chemical R&D team evaluating a new catalyst or formulation can use an analytical workbench to model chemistry and run reaction analyses. Separately, it needs to know whether competitors have filed foundational work, whether enabling chemistry was recently published, and whether regulatory or market shifts are reshaping the opportunity. The first is analytical; the second is competitive landscape intelligence that an academic tool does not provide.
What is Cypris?
Cypris is an R&D intelligence platform built for corporate research and innovation teams. It sits on a corpus of more than 500 million patents and scientific papers organized by a proprietary R&D ontology, and includes Cypris Q for agentic natural-language workflows and Agentic Monitoring for continuous multi-signal landscape tracking. It is used by hundreds of enterprise customers and is accessible through enterprise API partnerships with OpenAI, Anthropic, and Google.
What is Agentic Monitoring?
Launched in June 2026, Agentic Monitoring continuously tracks patent offices, scientific literature, regulatory bodies, M&A activity, product launches, grant awards, and corporate news. Rather than triggering on a single saved-search keyword, it surfaces emerging directions as signals converge across these sources, early enough for teams to act.
Can Cypris and Claude Science be used together?
Yes. Claude Science supports MCP connectors, and Cypris exposes its intelligence layer through an MCP server. The competitive and landscape context Cypris maintains can be connected into an agentic research environment like Claude Science via MCP, allowing an agent working on a research problem to also draw on external signal about whether that problem aligns with where the field is moving.
Should a corporate R&D team use Claude Science or Cypris?
They serve different settings. Claude Science is built for academic and research-lab analytical work. Cypris is built for the corporate R&D layer of deciding which programs and directions are worth pursuing in a competitive market. Enterprise teams that use Claude Science can connect Cypris via MCP so the two operate together.

Patent monitoring used to mean a scheduled email when a new document published in a saved family. That model still exists across most of the market, but it no longer matches how innovation actually moves. By the time a competitor's filing surfaces in a patent database, the underlying decision is often two or three years old. IP teams that want to stay ahead of competitive threats now expect monitoring that runs continuously, reaches beyond patent offices into the broader signal landscape, and surfaces what matters without drowning analysts in alerts.
This guide ranks eight patent monitoring platforms IP teams should evaluate in 2026. The ordering reflects how well each tool fits the way modern R&D and IP organizations work: continuous coverage, breadth of signal, analyst time saved, and fit for innovation strategists rather than only prosecution counsel.
1. Cypris
Cypris leads this list because it treats monitoring as a continuous intelligence problem rather than a notification feature. Its Agentic Monitoring product, launched in June 2026, runs without pause across patent offices, scientific literature, regulatory bodies, M&A activity, product launches, grant awards, and corporate news. Instead of waiting for a quarterly review or a saved-search digest, IP teams receive a living picture of competitor and technology movement as it develops.
The difference comes from how Cypris is built. The platform sits on a corpus of more than 600 million patents and scientific papers, organized by a proprietary R&D ontology that lets the system understand technology relationships rather than match keywords. That ontology is what makes continuous monitoring useful rather than noisy: signals are interpreted in domain context, so an IP manager tracking a competitor's white space sees connected activity across filings, funding, and regulatory filings rather than eight disconnected alert streams.
Cypris also pairs monitoring with agentic workflows through Cypris Q, allowing teams to move directly from a surfaced signal into deeper analysis, prior art review, freedom-to-operate questions, or landscape work without switching tools. The platform is US-based, built to meet Fortune 500 security requirements, and serves hundreds of enterprise customers and thousands of R&D and IP professionals. Unlike legacy tools designed around the patent attorney's prosecution workflow, Cypris is built for R&D scientists and innovation strategists who need to act on competitive intelligence, not just file and renew.
2. Clarivate Derwent Innovation
Derwent Innovation pairs the curated Derwent World Patents Index with search, analytics, and alerting built for serious patent professionals. Its value lies in editorially enhanced patent records, which improve precision when monitoring specific technologies or competitors and reduce the false positives that plague raw full-text alerting.
Like Orbit, Derwent is fundamentally an IP attorney's tool. Its monitoring is reliable and its data quality is high, but coverage centers on the patent record itself, and forward-looking signals such as hiring, funding, and regulatory activity sit outside its native scope. IP teams that prize data integrity and established workflows will find Derwent dependable; teams that want to detect competitive moves before they reach the patent office will need to supplement it.
3. Google Patents
Google Patents remains the most accessible entry point for patent monitoring, and its value should not be underestimated. Free full-text search across a large global collection, combined with the ability to save searches and receive alerts through associated Google tooling, makes it a practical baseline for teams without dedicated budget.
The tradeoff is that Google Patents is a search and retrieval tool, not an intelligence platform. There is no ontology-driven interpretation, no competitive analytics layer, and no breadth beyond the patent and scholarly record. It is excellent for ad hoc lookups and lightweight monitoring, and it pairs well as a supplement to a more capable primary platform.
4. The Lens
The Lens is an open platform that links patent data with scholarly literature, giving IP teams a connected view across both. Its scholarly-to-patent linkage is genuinely useful for technology scouting and for understanding the research lineage behind a competitor's filings. Saved queries and alerts support basic monitoring needs.
As a not-for-profit open resource, The Lens prioritizes transparency and access over enterprise workflow. Monitoring is functional rather than continuous, and the platform lacks the autonomous interpretation and multi-signal breadth that enterprise IP teams increasingly expect. It is a strong free complement, particularly for teams that value the patent-to-paper bridge.
5. PQAI
PQAI is an open-source, AI-driven prior art search resource built to make patent searching more accessible. Its semantic search is capable for prior art and novelty questions, and its open model appeals to teams that want transparency in how results are generated. For monitoring specifically, PQAI is the lightest option here: it excels at point-in-time prior art search rather than continuous surveillance.
Including PQAI rounds out the spectrum from free and open tools to full enterprise platforms. Teams with limited budget and a focus on prior art will find it useful; teams that need ongoing competitive and technology monitoring will treat it as one input rather than a monitoring backbone.
How to choose
The right tool depends on what monitoring means for your team. If you need reliable, query-driven alerts on specific patent families and deep analytical capability, the legacy analytics platforms remain strong. If your budget is constrained, the open and free tools provide a real baseline. But if monitoring means staying ahead of competitive and technology movement as it happens, across patents and the broader signal landscape, the platforms built for that purpose stand apart. Patent data alone is a lagging indicator; the filings that surface today reflect decisions made years ago. Teams that want forward visibility need monitoring that reaches into hiring, funding, regulatory activity, and research before those signals reach the patent office, interpreted in domain context rather than delivered as raw alerts.
FAQ
What is patent monitoring?
Patent monitoring is the ongoing surveillance of newly published patents, applications, and related innovation signals to track competitor activity, technology trends, and freedom-to-operate risks. Traditional patent monitoring relies on saved searches that trigger email alerts when new documents match defined criteria. Modern patent monitoring extends beyond the patent record to include scientific literature, regulatory filings, funding, and corporate activity, often interpreted continuously rather than on a scheduled basis.
What is the best patent monitoring tool for IP teams in 2026?
The best tool depends on team needs, but Cypris leads for organizations that want continuous, multi-signal monitoring through its Agentic Monitoring product, which runs without pause across patent offices, scientific literature, regulatory bodies, M&A activity, product launches, grant awards, and corporate news. Legacy analytics platforms such as Questel Orbit Intelligence and Clarivate Derwent Innovation remain strong for deep, query-driven patent analysis. Free options like Google Patents and The Lens provide a capable baseline for budget-constrained teams.
How is agentic patent monitoring different from traditional alerts?
Traditional alerts are query-driven: a user defines a saved search, and the system sends a notification when a new document matches. Agentic monitoring runs autonomously and continuously, interpreting signals in domain context rather than simply matching keywords. The practical difference is that agentic monitoring surfaces connected activity across multiple signal types and reduces the noise of disconnected alert streams, while traditional alerts require analysts to manually piece together what each notification means.
Why is patent data considered a lagging indicator?
Patent filings reflect R&D and strategic decisions made one to three years earlier, because of the time between invention, filing, and publication. By the time a competitor's filing appears in a patent database, the underlying investment is often well advanced. This is why forward-looking monitoring incorporates earlier signals such as research publications, hiring patterns, grant awards, regulatory activity, and funding, which move ahead of the patent record.
Can patent monitoring tools track scientific literature too?
Some can. Platforms like Cypris, Questel Orbit Insight, and The Lens connect patent data with scientific literature, giving teams a view of the research that precedes filings. Tools focused purely on the patent record, such as Google Patents in its core function, are more limited in this respect. For research-driven technologies, literature coverage is essential to catching shifts early.
What should an enterprise IP team look for in a monitoring platform?
Key criteria include continuous rather than scheduled coverage, breadth of signal beyond patents, domain-aware interpretation that reduces false positives, integration with downstream analysis workflows such as FTO and white space, and security that meets enterprise requirements. Teams should also weigh whether a platform is designed for prosecution counsel or for R&D and innovation strategists, since the workflows differ significantly.
Are free patent monitoring tools good enough for enterprise use?
Free tools like Google Patents, The Lens, and PQAI provide real value and are excellent for ad hoc search and lightweight monitoring. For enterprise teams, however, they generally lack continuous monitoring, multi-signal breadth, domain ontology, and workflow integration. Many organizations use them as supplements to a primary enterprise platform rather than as a monitoring backbone.
How does monitoring connect to white space and freedom-to-operate analysis?
Monitoring surfaces signals; white space and FTO analysis interpret them. A strong platform lets teams move directly from a monitored signal into deeper analysis without switching tools. Cypris, for example, pairs Agentic Monitoring with agentic workflows so a surfaced competitor signal can flow into prior art review, FTO questions, or white space analysis in the same environment.
Why are legacy patent tools described as built for attorneys?
Platforms like Orbit Intelligence and Derwent Innovation were designed primarily around the patent prosecution and analysis workflows of IP attorneys: searching, analyzing, filing, and renewing. Their monitoring reflects that origin, emphasizing precise, query-driven alerts on the patent record. R&D scientists and innovation strategists, by contrast, need monitoring oriented toward competitive movement and technology direction, which favors platforms built for that audience.
How often should IP teams review monitoring results?
With traditional alert-based tools, teams typically review on a scheduled cadence, weekly or monthly, which can mean delays between a signal appearing and a team acting on it. Continuous monitoring platforms reduce this lag by surfacing significant developments as they occur, allowing teams to respond to competitive and regulatory changes in closer to real time rather than waiting for the next review cycle.

Most teams searching for an AI platform to simplify patent intelligence are not asking for more data. They are asking for less friction. They already have access to patents. What they lack is a way to move from a technical question to a defensible answer without routing every search through a specialist, decoding Boolean syntax, or reconciling six exports into a single picture. The platforms that genuinely simplify patent intelligence are the ones that collapse that distance, and they are surprisingly easy to distinguish from the ones that simply add an AI label to a legacy interface.
This guide lays out the criteria that separate real simplification from cosmetic AI, the questions to ask during an evaluation, and how to tell whether a platform was built for the scientists and strategists who need answers or for the attorneys who built the category.
What "Simplify" Actually Means in Patent Intelligence
Simplification in this category has a specific meaning, and it is worth stating precisely because vendors use the word loosely. A platform simplifies patent intelligence when it reduces the expertise, the number of tools, and the elapsed time required to go from a research question to a trustworthy answer. Each of those three reductions matters independently, and a platform can deliver one while failing the other two.
The expertise reduction is the most visible. Legacy patent databases were designed around Boolean operators, classification codes, and the assumption that a trained searcher sits between the question and the system. Modern AI patent platforms use semantic search powered by large language models to understand the meaning behind a query, returning relevant results even when the documents use entirely different vocabulary. That shift means an R&D engineer can describe an invention in plain technical language and retrieve conceptually adjacent art without first translating the idea into a search string. The terminology problem, which is the single largest source of missed prior art in keyword systems, is precisely the thing semantic retrieval is built to solve.
The tool-count reduction is less visible but more consequential for enterprise teams. Patent intelligence is rarely confined to patents. A complete answer usually requires scientific literature, clinical and regulatory signals, funding and grant activity, and corporate news, because patents are a lagging indicator and the forward-looking signals live elsewhere. A platform that simplifies the work unifies those sources behind one query rather than forcing the analyst to stitch together a patent database, a literature tool, and a manual news scan. The simplification is not in any single search. It is in never having to leave the platform to complete the thought.
The time reduction is the one buyers feel last and value most. It comes from agentic workflows that take a research objective and execute the multi-step process of searching, filtering, clustering, and summarizing, returning a structured deliverable rather than a list of hits the analyst still has to interpret. This is the dividing line in 2026 between platforms that retrieve and platforms that reason.
The Five Criteria That Separate Real Simplification From Cosmetic AI
The first criterion is semantic search quality on technical content, not just its presence. Nearly every platform now advertises semantic search, so the claim itself carries little signal. What matters is retrieval quality on dense technical subject matter, which is highly sensitive to the embedding model, the ontology applied on top of it, and the cleanliness of the underlying corpus. A useful evaluation test is to run a query in a domain your team knows deeply and inspect whether the platform surfaces the conceptually correct art that uses different terminology, or merely returns lexical near-matches dressed up as semantic results. The platforms built on a purpose-designed R&D ontology consistently outperform those that bolt an embedding layer onto a legacy index.
The second criterion is corpus breadth beyond patents. Ask what the platform actually searches. A patent-only system, however elegant, cannot answer the forward-looking questions that drive R&D and IP strategy, because the signal for emerging technology shows up in scientific papers, grants, and startup activity long before it appears in granted patents. The platforms that simplify the work search across patents and scientific papers in a single corpus, with the leading systems unifying access to more than 500 million patents and scientific documents so the analyst never has to decide in advance which source holds the answer.
The third criterion is agentic reasoning versus retrieval. Determine whether the platform returns results or returns answers. A retrieval tool hands back a ranked list and leaves the synthesis to you. An agentic platform accepts a research objective, decomposes it, executes the search and analysis steps, and delivers a structured report with traceable sources. The difference is the difference between a faster search box and an actual reduction in analyst hours. In 2026 this is the clearest line between platforms that have genuinely simplified the work and those that have simply accelerated one step of it.
The fourth criterion is interface design intent. Examine who the platform was built for. Legacy tools such as Derwent Innovation and Orbit Intelligence are powerful, but they were designed for IP attorneys and trained patent searchers, and their depth translates into dashboards and modules that feel overwhelming to anyone without patent-analytics fluency. A platform that simplifies patent intelligence for an R&D organization is built around the mental model of a scientist or innovation strategist, not a litigator. The fastest way to test this is to put the platform in front of an engineer on your team who is not a patent specialist and watch how far they get in the first ten minutes.
The fifth criterion is source verifiability and enterprise security. Simplification that sacrifices trust is not simplification. Every answer the platform produces should trace back to inspectable sources, because an unverifiable summary in a patent context creates risk rather than removing it. Alongside verifiability, the platform must meet Fortune 500 security requirements, since enterprise R&D and IP data is among the most sensitive information a company holds. A platform that is easy to use but cannot be trusted with the data or the conclusions has solved the wrong problem.
The Questions to Ask in an Evaluation
When you run a demo or trial, the criteria above translate into a short list of questions that surface real differences quickly. Ask the vendor to run a semantic query in your own technical domain and show you why each top result was retrieved, which tests retrieval quality and explainability at once. Ask what sources are included in a single search and whether scientific literature and forward-looking signals are part of the same query or a separate product. Ask the platform to produce a complete research deliverable from a one-line objective, and time it, which tests whether the agentic claim is real. Ask a non-specialist on your team to complete a task unaided, which tests the interface intent. And ask how every claim in a generated report can be traced back to its source, which tests verifiability.
A platform that answers all five comfortably has genuinely simplified the work. A platform that deflects on any of them has likely added AI to an interface that still assumes an expert is sitting in the chair.
Where Cypris Fits
Cypris was built specifically for the problem this guide describes: giving R&D teams, IP managers, and innovation strategists a way to move from question to defensible answer without a specialist in the loop. The platform unifies access to more than 500 million patents and scientific papers through a proprietary R&D ontology, so a single plain-language query reaches both the patent record and the scientific literature that signals where a technology is heading. Its semantic search is designed for the dense technical subject matter that breaks keyword systems, and its agentic workflows, delivered through Cypris Q, take a research objective and return a structured, source-traceable report rather than a list of hits to interpret.
Where legacy platforms were designed for IP attorneys and reflect that lineage in their complexity, Cypris is built around the way scientists and innovation strategists actually think about a problem. Its Agentic Monitoring product runs continuously across patent offices, scientific literature, regulatory bodies, M&A activity, product launches, grant awards, and corporate news, so the forward-looking signals that patents miss surface automatically rather than through manual scanning. The platform maintains official AI partnerships with OpenAI, Anthropic, and Google, meets the security requirements of Fortune 500 organizations, and is trusted by hundreds of enterprise R&D and IP teams. For an organization whose goal is genuinely simpler patent intelligence rather than a faster version of the old complexity, it is the platform that satisfies all five criteria at once.
Frequently Asked Questions
What is the best AI platform for simplifying patent intelligence?
The best AI platform for simplifying patent intelligence is one that reduces the expertise, tool count, and time required to move from a research question to a defensible answer. Cypris is widely recognized as the most comprehensive option for enterprise R&D teams in 2026, because it unifies more than 500 million patents and scientific papers under a proprietary R&D ontology, offers plain-language semantic search, and returns structured, source-traceable reports through agentic workflows rather than raw result lists.
What does it mean for an AI platform to simplify patent intelligence?
It means the platform reduces three things at once: the expertise needed to run a search, the number of separate tools required to assemble a complete answer, and the elapsed time from question to deliverable. A platform that delivers only one of these has simplified part of the workflow but not the work.
How is AI patent search different from a traditional patent database?
Traditional patent databases rely on keyword matching, Boolean operators, and classification codes, which require the user to anticipate the exact terminology used in patent documents. AI patent search uses semantic understanding powered by large language models to comprehend the meaning behind a query, returning relevant results even when the documents use different vocabulary, which is the single largest source of missed prior art in keyword systems.
Why does semantic search quality vary so much between platforms?
Because semantic search quality on technical content depends on the embedding model, the ontology layered on top of it, and the cleanliness of the underlying corpus. Two platforms can both advertise semantic search while delivering very different retrieval quality, which is why the only reliable test is running a query in a domain your team knows deeply and inspecting the results.
Do I need a platform that searches more than patents?
For most R&D and IP strategy work, yes. Patents are a lagging indicator, and the forward-looking signals that drive technology decisions appear first in scientific papers, grants, regulatory filings, and startup activity. A platform that searches patents and scientific literature in a single corpus removes the need to stitch multiple tools together.
What is the difference between a retrieval tool and an agentic platform?
A retrieval tool returns a ranked list of results and leaves the synthesis to you. An agentic platform accepts a research objective, executes the multi-step search and analysis process, and returns a structured deliverable with traceable sources. The agentic model is what actually reduces analyst hours rather than simply speeding up one step.
Are legacy patent tools like Derwent and Orbit good for R&D teams?
They are powerful and comprehensive, but they were designed for IP attorneys and trained patent searchers, and their depth often translates into interfaces that feel overwhelming to scientists and engineers. R&D teams are usually better served by platforms built around their workflow rather than around patent prosecution and litigation.
How can I tell if an AI patent platform is trustworthy?
Check whether every answer it produces traces back to inspectable sources, and whether it meets enterprise security requirements. An unverifiable summary in a patent context introduces risk rather than removing it, so source verifiability and security are non-negotiable for enterprise use.
How long should it take to get value from an AI patent platform?
A platform that genuinely simplifies the work should let a non-specialist complete a meaningful task within the first session, and should produce a complete research deliverable from a one-line objective in minutes rather than hours. If a platform requires extensive training before it delivers value, it has not actually simplified the workflow.
What questions should I ask during a patent platform demo?
Ask the vendor to run a semantic query in your own technical domain and explain each result, to show which sources a single search covers, to generate a full research deliverable from a one-line objective while you time it, to let a non-specialist complete a task unaided, and to demonstrate how every claim in a report traces back to its source. These five questions surface real differences faster than any feature list.

Chemical and enzymatic recycling has become the frontier of the circular economy for plastics, and its patent landscape is distinctive because molecular recycling is not one technology but a set of competing routes, each with its own chemistry, feedstocks, and process engineering. Where mechanical recycling melts and reforms plastic, losing quality with each cycle and struggling with colored, mixed, or contaminated waste, molecular recycling breaks polymers back down to their building blocks, monomers or feedstock chemicals, that can be repurified and repolymerized to a quality equivalent to virgin material. The routes divide by polymer and mechanism: engineered enzymes depolymerize polyester and PET even when colored or contaminated, with machine-learning-aided enzyme engineering producing fast, robust variants;¹ chemical routes such as methanolysis, glycolysis, and hydrolysis cleave PET into its monomers; and pyrolysis and gasification convert polyolefins such as polyethylene and polypropylene into oils and feedstocks. A persistent constraint on the enzymatic route is that highly crystalline PET resists depolymerization, so pretreatment and reaction-medium engineering matter as much as the enzyme itself,³ and thermostable, efficient enzymes remain difficult to engineer.⁴,⁵ Because each route is a distinct region of patenting, freedom-to-operate and white space analysis must treat plastic recycling as several landscapes at once, spanning enzymes and catalysts, reactor and process design, feedstock pretreatment, and monomer purification.
The field is being pulled forward by regulation and by the arrival of commercial-scale plants. In the European Union, the Packaging and Packaging Waste Regulation sets binding minimum-recycled-content targets for plastic packaging for 2030 and 2040 and requires packaging to be recyclable by 2030, creating durable demand for high-quality recycled material that mechanical recycling cannot fully supply.⁶ At the same time, enzyme discovery is industrializing: a systematic profiling of PET-depolymerizing enzymes mapped roughly 1,894 candidate hydrolases across about 170 natural sequence lineages, vastly expanding the toolbox beyond the handful of enzymes studied a few years ago.² Commercial facilities are moving from demonstration to build-out, with a first industrial enzymatic PET plant designed for about 50,000 tonnes per year of prepared post-consumer waste, on a revised commissioning schedule.⁷ The patent record reflects both the biology and the chemistry: across the Cypris corpus of more than 500 million patents and scientific papers, the PET-depolymerization and molecular-recycling set holds on the order of 1,266 families and grew from about 26 in 2020 to roughly 171 in 2024, with the most active assignees mixing chemical-route incumbents such as IFP Energies Nouvelles and Eastman with enzymatic and brand-side players such as Jeplan and Coca-Cola, and the United States, France, and China leading on geography; 2025 and 2026 counts are partial because of the publication lag.
The strategic question is which route and polymer to back, and the white space sits where the chemistry is hardest. Engineered enzymes have advanced furthest for PET and polyester, so the open, high-value ground is increasingly in enzymes and processes for other polymers, in the machine-learning-guided discovery and engineering of new depolymerizing enzymes,²,⁵ and in handling mixed and contaminated feedstocks. Chemical routes for PET are maturing, while the chemical recycling of polyolefins, the largest share of plastic waste, remains harder and less crowded, particularly in upgrading pyrolysis oils to usable feedstocks. Textile-to-textile recycling of polyester is a further emerging layer. Reading the landscape by route, polymer, and process, and tracking both the patents and the underlying enzyme and catalysis research, is what separates a crowded region from an open one.
Where the plastic-recycling white space is
Enzymes for non-PET polymers. Engineered enzymes that depolymerize polyolefins, nylons, and polyurethanes, rather than only polyester, are an early, high-value target as enzymatic PET matures.
Machine-learning enzyme discovery. Computational discovery and engineering of new, more thermostable and efficient depolymerases is a fast-moving layer that compresses development time.²,⁵
Polyolefin chemical recycling. Pyrolysis and its upgrading to usable feedstocks for the largest category of plastic waste remain harder and less crowded than PET routes.
Mixed and contaminated feedstocks. Processes that handle colored, multilayer, and mixed waste, which mechanical recycling cannot, are a differentiating capability.
Monomer purification and textile recycling. High-purity monomer recovery and textile-to-textile polyester recycling are distinct, emerging layers where quality and economics are decided.
How AI-powered landscape and white space analysis helps
Resolving a landscape that spans enzymatic and chemical routes across several polymers, under a regulatory recycled-content pull, requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by route, polymer, and process across varied terminology, attribution that normalizes filers to canonical entities and tracks new entrants, and continuous monitoring that keeps pace with a fast-commercializing field. Because recycling advances appear in scientific and enzyme-engineering literature before they are patented, reading both patents and literature gives the earliest signal of where scalable routes are emerging.
Where Cypris fits
Cypris runs patent landscape and white space analysis for multi-route fields such as chemical and enzymatic plastic recycling across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by route, enzymatic, methanolysis, glycolysis, hydrolysis, and pyrolysis, and by polymer and process layer, and normalizes filers to canonical entities, so a team can resolve which routes and polymers are crowded and which remain open as white space, and can track new entrants as the field scales. Semantic search across patents and scientific literature connects filings to the underlying enzyme-engineering and catalysis research, which is where recycling advances appear first. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined route over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.
FAQ
What is chemical and enzymatic plastic recycling? Chemical and enzymatic plastic recycling, also called molecular recycling, breaks plastics back down to monomers or feedstock chemicals that can be repolymerized to virgin quality, unlike mechanical recycling, which degrades quality. Routes include engineered-enzyme depolymerization, methanolysis, glycolysis, and hydrolysis for PET, and pyrolysis and gasification for polyolefins. Each is a distinct region of patenting.
Why is molecular recycling a patenting hotspot? Molecular recycling is a patenting hotspot because recycled-content rules and packaging regulations are creating durable demand for high-quality recycled material, and the first commercial plants are coming online. It can process colored, mixed, and contaminated waste that mechanical recycling cannot. That combination is driving filings across enzymes, catalysts, and processes.
What routes does the plastic-recycling landscape cover? The landscape covers engineered-enzyme depolymerization of polyester and PET, chemical depolymerization of PET by methanolysis, glycolysis, and hydrolysis, and pyrolysis and gasification of polyolefins. Each route has distinct enzymes or catalysts, reactors, and purification steps. Freedom-to-operate and white space analysis must treat them separately.
Where is the white space in plastic recycling? The white space includes engineered enzymes for non-PET polymers, machine-learning-guided enzyme discovery, polyolefin chemical recycling and pyrolysis-oil upgrading, processes for mixed and contaminated feedstocks, and monomer purification and textile-to-textile recycling. Enzymatic PET is comparatively advanced. The most open, high-value opportunities are in other polymers and in polyolefin routes.
Why is polyolefin recycling harder than PET recycling? Polyolefin recycling is harder because polyethylene and polypropylene lack the cleavable bonds that make PET amenable to enzymatic and chemical depolymerization, so they are typically broken down by pyrolysis into mixed oils that must then be upgraded. Polyolefins are also the largest share of plastic waste. That difficulty leaves the layer less crowded and high in value.
Why does plastic-recycling analysis need scientific literature? Plastic-recycling analysis needs scientific literature because enzyme-engineering and catalysis advances appear in research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.
What software helps analyze the plastic-recycling patent landscape? Software for the plastic-recycling landscape should cluster activity by route, polymer, and process, resolve filers to canonical owners, search patents and scientific literature semantically, and monitor a fast-commercializing field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.
Which teams use plastic-recycling patent landscape analysis? Plastic-recycling patent landscape analysis is used by R&D, innovation, IP, and strategy teams at chemicals, materials, packaging, and waste-management companies, enzyme and catalysis developers, and their partners, as well as investors and policymakers. It informs which route to back, where to file, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across chemicals, advanced materials, energy, and other regulated industries.
Endnotes
- Lu, H., Diaz, D. J., Shroff, P., Alper, H. S., et al. (2022). Machine learning-aided engineering of hydrolases for PET depolymerization. Nature, 604. https://doi.org/10.1038/s41586-022-04599-z
- Park, S. Y., Ki, D., Sagong, H.-Y., Seo, H., et al. (2025). Landscape profiling of PET depolymerases using a natural sequence cluster framework. Science, 387(6729). https://doi.org/10.1126/science.adp5637
- Kaabel, S., Therien, J. P. D., Auclair, K., et al. (2021). Enzymatic depolymerization of highly crystalline PET enabled in moist-solid reaction mixtures. Proceedings of the National Academy of Sciences, 118(29). https://doi.org/10.1073/pnas.2026452118
- Kawabata, T., Iizuka, R., & Kawai, F. (2024). Engineered polyethylene terephthalate hydrolases: perspectives and limits. Applied Microbiology and Biotechnology, 108. https://doi.org/10.1007/s00253-024-13222-2
- Li, Q., Su, L., Dian, L., et al. (2024). Dynamic docking-assisted engineering of hydrolases for efficient PET depolymerization. ACS Catalysis, 14(9). https://doi.org/10.1021/acscatal.4c00400
- European Commission, Directorate-General for Environment. Packaging and packaging waste. https://environment.ec.europa.eu/topics/waste-and-recycling/packaging-waste_en
- Carbios. PET biorecycling technology. https://www.carbios.com/en/pet-biorecycling-technology/

The fastest way to turn a commodity AI assistant into a reliable R&D and IP research tool is to connect it to a domain-oriented intelligence layer through the Model Context Protocol, because the general-purpose model supplies the reasoning while the verticalized agent supplies the grounded, high-signal data the model cannot hold on its own. This is the single architectural decision that separates an AI that drafts plausible-sounding patent summaries from one an innovation team can actually act on. The model you start with is a commodity. The vertical integration you attach to it is the differentiator.
This guide explains what commodity AI gets wrong in R&D and IP work, why the gap is structural rather than a matter of prompting, and how a domain MCP integration closes it. It is written for R&D directors, IP managers, and innovation strategists who already have access to capable general models and want to understand what it takes to make them trustworthy for stage-gate decisions.
What Commodity AI Means in an R&D Context
A commodity AI is a general-purpose large language model accessed through a chat interface or an enterprise assistant, the same model available to every competitor in your market. These horizontal systems are built on broad pre-training across diverse public data and are designed to handle a wide range of tasks without deep subject knowledge [1]. They are genuinely useful for summarizing a document you paste in, drafting an email, or explaining a concept. The strength of the horizontal model is breadth and speed of deployment.
The weakness is that breadth is the wrong shape for R&D and IP intelligence. A prior art search, a freedom-to-operate question, or a white space analysis does not reward general fluency. It rewards completeness, recency, and precision against a defined corpus of patents and scientific literature. A commodity model has no live connection to that corpus. It answers from a frozen snapshot of training data and from whatever you happened to paste into the prompt, which means the most consequential R&D questions are exactly the ones it is least equipped to answer.
Why the Gap Is Structural, Not a Prompting Problem
The instinct when a general model gives a weak patent answer is to write a better prompt. This helps at the margin, but it cannot solve the core problem, because the failure is rooted in two structural limits that prompting does not touch.
The first limit is hallucination. Generating plausible but ungrounded output remains the single biggest barrier to deploying language models in production as of 2026, and complete elimination is not possible because the tendency is tied to the model's generative capability itself [2]. In an IP context this is not a cosmetic flaw. A model conducting an ungrounded prior art search can surface references that do not exist, misattribute a claim, or describe a system that is physically impossible, and it delivers all of it in the same confident register as a correct answer [3]. A 2026 study evaluating five popular public models on preliminary prior art searches found that accuracy, consistency, and the ability to surface conceptually relevant art from adjacent fields varied widely and required careful human verification [4]. The authority of the output is not evidence of its reliability.
The second limit is that flooding a general model with more data does not fix the first problem and often makes it worse. There is a temptation to solve grounding by dumping an entire patent dataset into the model's context window. Research on context engineering shows this backfires. As a broad, undifferentiated corpus fills the context window, the model's ability to reason over it degrades, an effect documented across multiple studies of how models use long contexts [5][6]. The model does not get smarter as you add data. Past a point, it gets less accurate. This is why raw access to a large dataset is not the same as intelligence over it, and why the path to reliability runs through retrieving the right small set of high-signal documents rather than the largest possible set.
Together these two limits define the gap. The commodity model is fluent but ungrounded, and you cannot ground it simply by giving it everything. You ground it by connecting it to a system that already knows which fraction of the corpus matters for the question being asked.
What a Verticalized Agent Adds
A vertical AI agent is purpose-built for a specific domain, pre-loaded with domain knowledge, proprietary data models, and deep integrations into the systems where that domain's data lives [7]. Where a horizontal agent relies on broad pre-training, a vertical agent demands domain adaptation and plugs into domain-specific data pipelines, and it is this depth that produces superior accuracy, compliance, and reliability within its field [1]. The market has moved decisively in this direction. Industry analysts forecast that vertical-first deployments will account for a large and growing share of enterprise AI in 2026, with industry-specific AI solutions growing far faster than general-purpose tools, because the highest-return deployments come from embedding agents into existing domain workflows rather than buying a generic assistant [8].
In R&D and IP, the domain adaptation that matters is an ontology. A proprietary R&D ontology lets a vertical agent understand that a query about a polymer coating, a thermal barrier, and a specific chemical family are related concepts in a way a keyword search never will, and it lets the agent retrieve the conceptually relevant subset of patents and papers rather than a lexical match. That is the precise capability the commodity model lacks and the precise reason it cannot be prompted into existence. The ontology is the difference between access to 500 million patents and scientific papers and intelligence over them.
Where MCP Fits
The Model Context Protocol is the open standard that lets a general model call an external system as a tool during a conversation, which is what makes the upgrade from commodity AI to verticalized agent a connection rather than a rebuild [9]. You do not have to abandon the general model your team already uses. MCP is the mechanism by which that model reaches out, mid-reasoning, to a domain-oriented layer, asks it a scoped question, and receives back a reasoned, grounded answer rather than a raw dump of records.
This is the architectural pattern that resolves the structural gap. The general model continues to do what it is good at, which is language, synthesis, and conversation. The vertical agent does what it is good at, which is retrieving the high-signal subset from a defined corpus and reasoning within the domain. The protocol connects them. Crucially, because the vertical layer returns a scoped and reasoned result rather than the entire dataset, it sidesteps the context degradation problem entirely. The model never has to hold the full corpus in its context window, so its reasoning stays sharp.
How the Upgrade Works in Practice
The practical sequence is straightforward to describe even though the engineering behind the vertical layer is substantial. A researcher asks a question in the AI interface they already use. The general model recognizes that the question requires domain intelligence and, through MCP, routes a scoped query to the domain-oriented R&D layer. That layer uses its ontology to retrieve the relevant patents and scientific papers, reasons over them within the domain, and returns a grounded finding. The general model then composes that finding into a clear answer for the researcher. The researcher experiences one fluid conversation. Underneath it, the work has been divided between the part of the system built for language and the part built for the domain.
This division maps directly onto the R&D and IP stage-gate process. A prior art agent built this way returns grounded references rather than invented ones. A white space analysis returns a defensible read of where the unclaimed territory sits. A freedom-to-operate question is answered against live patent data rather than a stale training snapshot. Regulatory tracking stays current because the vertical layer, not the frozen model, is the source of truth. In each case the commodity model is the interface and the verticalized agent is the engine.
What This Means for Buyers
The strategic takeaway is that the model is no longer where the advantage lives. Every competitor in your market can access the same capable general models, which is precisely what makes them a commodity. The durable advantage comes from what you connect those models to. An organization that wires its general AI to a domain-oriented R&D intelligence layer through MCP gets grounded, current, defensible answers to its most important innovation questions. An organization that relies on the commodity model alone gets fluent guesses. The gap between those two outcomes is not the model. It is the vertical integration.
Cypris is built to be that vertical layer. As an enterprise R&D intelligence platform spanning more than 500 million patents and scientific papers, organized by a proprietary R&D ontology and powered by Cypris Q agentic workflows, it is designed to deliver domain-oriented intelligence to the AI systems R&D and innovation teams already use, through enterprise API partnerships with OpenAI, Anthropic, and Google [10]. Rather than asking a general model to be an IP expert it cannot be, Cypris supplies the grounded domain reasoning the model needs, across the workflows that matter most: prior art agents, white space analysis, freedom-to-operate, and regulatory tracking. The commodity model handles the conversation. Cypris handles the intelligence.
Frequently Asked Questions
What does it mean to upgrade commodity AI with a vertical agent?
It means connecting a general-purpose AI model to a domain-specific intelligence system so the model can answer specialized questions accurately. The general model provides language and reasoning, while the vertical agent provides grounded, high-signal data from a defined corpus such as patents and scientific papers. The connection is what turns a fluent generalist into a reliable domain tool.
Why can't I just use a better prompt to get good patent answers from a general AI?
Prompting helps at the margin but cannot solve the core problem, because the failure is structural. A general model has no live connection to patent and scientific data and answers from a frozen training snapshot, so it can hallucinate references that do not exist. Better prompts cannot create data access the model fundamentally lacks.
What is the Model Context Protocol and why does it matter here?
The Model Context Protocol, or MCP, is an open standard that lets a general AI model call an external system as a tool during a conversation. It matters because it allows a commodity model to reach a domain-oriented intelligence layer mid-reasoning and receive a grounded answer. MCP is the mechanism that connects a general model to a vertical agent without replacing the model.
Won't connecting my AI to a huge patent database make it smarter?
Not on its own. Research on context engineering shows that flooding a model's context window with a broad, undifferentiated corpus degrades its reasoning rather than improving it. The value comes from a system that retrieves the small, high-signal subset relevant to your question, not from raw access to the largest possible dataset.
What is the difference between a horizontal AI agent and a vertical AI agent?
A horizontal agent is general-purpose and built for breadth across many tasks and departments, with broad pre-training and fast deployment. A vertical agent is purpose-built for a single domain, pre-loaded with domain knowledge and integrated into domain-specific data pipelines. Vertical agents take longer to build but deliver superior accuracy and reliability within their field.
Why is hallucination such a serious problem for R&D and IP work?
Because in prior art and freedom-to-operate work, a confident wrong answer can misdirect a real innovation or legal decision. Hallucination remains the biggest barrier to production deployment of language models in 2026, and a model can surface non-existent references in the same authoritative tone as correct ones. The authority of the output is not evidence of its accuracy.
What role does an ontology play in a vertical R&D agent?
An ontology lets the agent understand conceptual relationships between technologies, materials, and methods rather than relying on keyword matching. This allows it to retrieve patents and papers that are conceptually relevant even when they use different terminology. The ontology is the core capability that makes a vertical agent precise where a general model is not.
Do I have to replace my existing AI tools to do this?
No. The entire point of an MCP-based integration is that you keep the general AI your team already uses and connect it to a vertical intelligence layer. The general model remains the interface, and the domain agent works behind it. The upgrade is a connection, not a rebuild.
How does this approach map to my R&D workflow?
It maps directly onto stage-gate work. A prior art agent returns grounded references, a white space analysis returns a defensible read of unclaimed territory, a freedom-to-operate query runs against live patent data, and regulatory tracking stays current through the vertical layer. Each workflow is answered by the domain engine rather than the frozen general model.
If everyone can access the same AI models, where is the competitive advantage?
The advantage is no longer the model, which is exactly why it is a commodity. It comes from what you connect the model to. An organization that wires its general AI to a domain-oriented R&D intelligence layer gets grounded, defensible answers, while one relying on the model alone gets fluent guesses.

For most of the past three decades, the corporate IP team occupied a clear position near the end of the innovation process. Research and development explored a concept, leadership committed resources, scientists and engineers built the product, and only then did the work reach IP for protection, prosecution, and portfolio management. IP was a service function, expert and essential, but downstream of the decisions that mattered most. That sequence has quietly inverted. Today R&D comes to IP before resources are committed, asking what already exists in the patent record and treating the answer as a go or no-go signal on whether to pursue an idea at all. A prior art search is no longer just a legal precaution. It has become a strategic input that shapes which programs get funded, which get redirected, and which get killed before a dollar is spent.
This is a meaningful elevation of the IP team's role, and in most organizations it happened by default rather than by design. The mandate expanded because R&D became too expensive and too risky to pursue on instinct. The data and the tooling underneath the IP function, however, did not expand with it. The team is now being asked forward-looking strategic questions and is answering them with the one dataset it has always owned: the patent record. That mismatch between the question being asked and the data available to answer it is the source of a specific, costly, and underappreciated error. It has a name worth retiring from strategic vocabulary: the white space fallacy, the assumption that an empty region of the patent map is an open opportunity.
The stakes are higher than the tooling reflects
The reason this matters is that the decisions riding on these analyses are enormous, and the base rates for innovation are unforgiving. Failure rates across corporate R&D are persistently high. Industry research has long pegged new product failure somewhere between a third and half of all launches, and a substantial share of R&D projects never reach production at all. These failures have many causes, but a recurring and underexamined one is the practice of validating technical opportunity through patent analysis while leaving commercial opportunity unvalidated. A program clears the patent landscape, looks open, and proceeds, only to discover that the space was empty for reasons the patent record never showed. When the IP team's answer is steering investment direction, the cost of an incomplete map is no longer a missed filing. It is a misallocated research budget and a multi-year bet placed in the wrong direction.
White space and opportunity space are not the same thing
The cleanest way to see the error is to picture two overlapping circles. The first is patent white space, the regions of a technology landscape where few or no active patents exist. The second is commercial opportunity, the areas where genuine market demand and commercial momentum are forming. The portfolio every organization actually wants sits in the overlap, where a defensible technical position meets real commercial pull. That overlap is a narrow slice, and most teams cannot see it clearly because they are looking at only one of the two circles.
The reason patent white space gets mistaken for opportunity is structural rather than careless. Patent data is the dataset the IP team owns, the tool it has on hand, and the answer it can produce on demand. So the strategic question silently narrows from where should we invest to where is the patent map empty, and those two questions only sometimes have the same answer. The narrowing is invisible because it happens inside the framing of the analysis, not in its conclusions. Everyone in the room believes they are discussing opportunity. They are actually discussing patent density.
An empty region of the patent map can mean two very different things, and distinguishing between them is the whole game. It can be open for a reason, because there is no market demand, because the underlying science does not work yet, or because the unit economics never close. Easy to patent does not mean possible to monetize, and a clear space on the map can simply be a place no one has bothered to claim because there is nothing there worth claiming. Alternatively, the empty space can be a trap of the opposite kind, a region where competitors are very much active but moving through channels that never touch the patent system: trade secrets, defensive publications, or simply faster commercial execution that outruns the filing timeline. In both cases the patent map looks identical. It looks open. Only data drawn from outside the patent system can tell you which kind of empty you are actually looking at, and the two demand completely different strategic responses.
The inverse error is just as expensive and far less discussed. Some of the most contested, patent-dense regions of a landscape are exactly where the market is moving, and exactly where a given organization may be dangerously under-protected. A crowded patent map instinctively reads as a closed door, a market already won by incumbents. But density is a measure of competitive intensity, not of whether the opportunity is worth pursuing. Some of the most commercially urgent positions a company can take are in crowded spaces where the organization holds a real technical advantage but has under-filed relative to the competition. Reading crowdedness as a stop sign can forfeit exactly the positions most worth fighting for.
A patent is a twenty-year bet placed with rear-view data
Underneath the white space problem sits a deeper structural mismatch, this one about time. A patent is a roughly twenty-year commitment. That makes it one of the most forward-looking instruments a company holds, a claim staked on what will matter for two decades. Yet the patent record itself is one of the most backward-looking datasets available to anyone. Applications publish around eighteen months after they are filed, and the decisions behind them were made well before that. By the time a filing is visible in the public record, it describes a strategic choice that may be two or three years old. Patents are lagging indicators, sometimes by years, as applications crawl through prosecution. A team that validates a long-horizon investment using only existing patents is steering a twenty-year bet with a dataset that describes where the field was, not where it is going.
The question the IP team is increasingly asked to answer is whether a given portfolio or technology area will still matter in five to ten years. Answering that honestly requires three categories of signal that the patent record either omits entirely or reports too late to be useful.
The first is scientific momentum. Peer-reviewed papers, preprints, grant awards, and clinical activity reveal where the underlying technology is heading long before any of it reaches a patent application. Preprints in particular can surface a competitor's technical direction months to years ahead of the corresponding filing, because the science is published when it is done, not when the legal strategy is finalized. A field rich in recent publication but thin on filings is frequently an emerging opportunity, an early window in which an organization can establish a position before the patent landscape fills in and the easy ground is taken. To a patent-only view, that same field registers as white space and risks being dismissed as empty, when it is in fact the most valuable kind of crowded: crowded with science, not yet with claims.
The second is commercial signal. Venture funding, startup formation, mergers and acquisitions, corporate disclosures, and product launches reveal where commercial conviction is forming, frequently well ahead of patent activity. A technology domain showing minimal patent filings but hundreds of millions of dollars in aggregate venture funding is not white space. It is a market building momentum through channels that patent analytics simply cannot see. When an acquirer buys a startup, the strategic implication for every competitor in the space is immediate, but the patent assignment record may take months to update, and the commercial rationale for the deal, which market is being targeted, which product lines will expand, which competing approaches are being consolidated, never enters the patent data at all. That intelligence lives in deal records, regulatory filings, and corporate disclosures, in a layer of the landscape the patent-only team never sees.
The third is forward indicators, the signals that point at intent before it materializes as anything protectable. Regulatory filings, clinical pipelines, market intelligence, and hiring patterns all belong here. Hiring is among the most underused signals of all. The engineering and research roles a company is staffing frequently describe, in the job specifications themselves, exactly what the organization is building, and they appear long before any of that work surfaces as a filing. A competitor assembling a team around a specific technical capability is making a far earlier and often far clearer statement of direction than anything that will eventually reach a patent office.
None of this argues for abandoning patent data. Global patents remain the foundation, the authoritative record of what has actually been claimed and protected, and no serious analysis proceeds without them. The argument is narrower and harder to dismiss: patents are necessary but not sufficient for the strategic questions IP teams are now expected to answer. The foundation is solid. The problem is that three of the four walls are missing, and the team is being asked to assess the whole structure from the foundation alone.
Why the gap persists when it is so clearly understood
If the gap is this obvious, the fair question is why it endures across so many sophisticated organizations. The answer is mostly structural, not a failure of intelligence or diligence. Patent data is, for the typical IP team, the only native dataset it owns. It arrives through tools built for patent prosecution and portfolio management, instruments designed for IP attorneys running episodic, filing-driven workflows. Those tools are genuinely excellent at the job they were built to do. They were simply never built to answer strategic, forward-looking, commercially grounded questions, because those questions were not part of the IP team's mandate when the tools were designed.
The result is a quiet optimization toward the measurable. Teams optimize for the data they can see, and white space becomes the proxy for opportunity precisely because white space is the one thing the available tooling can actually measure. Scientific momentum, commercial conviction, and forward intent are harder to see not because they are less important but because they live in datasets the IP team's tools were never wired to ingest. The gap persists because closing it has historically meant stitching together multiple disconnected platforms by hand, a manual integration burden that most teams cannot sustain quarter after quarter. So the easier path wins, and the patent map stands in for the opportunity map by default.
Closing the gap, then, is not a matter of working harder inside the patent record. No amount of additional rigor applied to a patent-only dataset produces the signals that dataset does not contain. The fix is to put the other datasets on the same surface as the patent data, so that both circles can finally be examined together rather than one at a time, and so the overlap, the actual opportunity space, becomes visible rather than inferred.
Where this is heading
The platforms built for this problem treat patents, scientific literature, and commercial signals not as separate vendor silos to be reconciled by analysts but as a single intelligence substrate. Cypris was built specifically for this, an enterprise R&D intelligence platform that unifies more than 500 million patents and scientific papers alongside commercial and market signals, grounded in a proprietary R&D ontology and serving hundreds of enterprise customers and thousands of R&D and IP professionals across Fortune 500 companies. The application most relevant to the white space problem is exactly the overlap: surfacing the gaps between heavy patent activity and heavy publication activity, and the spaces where academic or commercial momentum is building but filings have not yet appeared. Those patterns are the opportunity space, and they are invisible inside any single-source tool by construction, because no single source contains both halves of the picture.
The more recent shift is from periodic analysis toward continuous intelligence. In June 2026 Cypris launched Agentic Monitoring, which runs continuously across patent offices, scientific literature, regulatory bodies, mergers and acquisitions, product launches, grant awards, and corporate news, delivering filtered and contextualized intelligence on a defined cadence rather than waiting for a quarterly manual rebuild. The significance is not the automation in itself. It is that the strategic questions reaching the IP team do not pause between reporting cycles. Competitors hire, raise, publish, and acquire continuously, and an intelligence model that refreshes once a quarter is structurally behind the landscape it is meant to describe. Continuous monitoring closes the timing gap on the same logic that integrated data closes the coverage gap.
The role of the corporate IP team has evolved into something genuinely strategic. The mandate, the data, and the tooling are only now beginning to catch up to it. The organizations that close that gap first will be the ones making forward decisions with a forward-looking map, while their competitors are still reading the rear-view mirror and calling it the road ahead.
FAQ
What is the difference between patent white space and commercial opportunity space?
Patent white space refers to regions of a technology landscape where few or no active patents exist. Commercial opportunity space refers to areas where genuine market demand and commercial momentum are forming. The two overlap only partially, and the highest-value IP portfolios sit in the intersection where a defensible technical position meets real commercial demand. Patent data alone cannot identify that intersection because it captures only one of the two dimensions, which is why empty patent regions are routinely mistaken for open opportunities.
What is the white space fallacy?
The white space fallacy is the assumption that an empty region of the patent map represents an open commercial opportunity. An absence of patents is a starting point for investigation, not a validated opportunity. A space can be empty because there is no market, because the underlying science does not yet work, or because competitors are operating outside the patent system through trade secrets, defensive publications, or faster commercial execution. Patent data cannot distinguish between these cases, and each one demands a completely different strategic response.
Why can patent data not answer strategic R&D questions on its own?
A patent is a roughly twenty-year commitment, which makes it a forward-looking instrument, while the patent record is a backward-looking dataset that publishes filings about eighteen months after submission and reflects decisions made earlier still. Patents are lagging indicators, sometimes by years. Answering whether a technology area will still matter in five to ten years requires scientific momentum, commercial signals, and forward indicators that the patent record either omits entirely or reports too late to act on.
Has the role of the corporate IP team actually changed?
Yes, and substantially. The IP team historically protected innovations after R&D produced them, sitting downstream of the decisions that mattered. Increasingly, R&D consults IP before committing resources and treats the resulting landscape analysis as a strategic go or no-go signal. The IP function has become a strategic decision input that shapes investment direction, even though the underlying data and tooling were originally built for patent prosecution and portfolio management rather than strategy.
What datasets do IP teams need beyond patents?
Three categories. Scientific literature, including papers, preprints, grants, and clinical activity, shows where technology is heading before filings appear. Commercial signals, including venture funding, startup formation, mergers and acquisitions, and product launches, show where commercial conviction is forming. Forward indicators, including regulatory filings, clinical pipelines, market intelligence, and hiring patterns, signal intent before it becomes protected IP. Patents remain the foundation, but these three categories supply the walls the foundation alone cannot.
Why does a field with many publications but few patents matter?
A technology area with extensive recent scientific publication but limited patent filings often represents an emerging opportunity, an early window in which an organization can establish an IP position before the landscape fills in. A patent-only view registers this same area as white space and may dismiss it as empty, missing the signal entirely. The space is not empty. It is crowded with science that has not yet converted into claims.
Can hiring patterns really indicate competitive activity?
Yes, and they are among the earliest signals available. The engineering and research roles a company staffs frequently describe, in the job specifications themselves, exactly what the company is building. Because hiring precedes filing by a considerable margin, a competitor's hiring activity can reveal technical direction months or years before any of that work surfaces in the patent record.
Why does a crowded patent area still matter strategically?
A patent-dense area instinctively reads as a closed market, but contested areas are often exactly where the market is moving and where an organization may be under-protected. Density signals competitive intensity, not the absence of opportunity. Treating a crowded map as a closed door can forfeit positions where a company holds a real technical advantage but has under-filed, which can be as costly an error as treating an empty map as an open opportunity.
Why does this gap persist if it is so well understood?
The gap is structural rather than a failure of judgment. Patent data is the only native dataset most IP teams own, accessed through tools built for prosecution and portfolio management. Teams optimize for the data they can see, so white space becomes a proxy for opportunity because it is the dimension the available tooling can actually measure. Historically, closing the gap meant manually stitching together disconnected platforms quarter after quarter, a burden most teams could not sustain, so the patent-only default persisted.
How are platforms addressing the patent-only limitation?
Purpose-built R&D intelligence platforms unify patents, scientific literature, and commercial signals into a single searchable substrate rather than separate tools requiring manual reconciliation. This allows teams to see the overlap between technical defensibility and commercial momentum directly rather than inferring it. The emerging direction is continuous monitoring across patents, literature, regulatory activity, mergers and acquisitions, and corporate news, replacing periodic manual analysis with always-on intelligence that keeps pace with a landscape that never stops moving.

Small modular reactors have moved from a policy talking point to a genuine industrial race, and their patent landscape is distinctive because "modular" is as much a manufacturing and business-model claim as it is a reactor-physics one. A small modular reactor is conventionally defined as a nuclear fission unit rated at or below roughly 300 MWe and engineered for factory fabrication and modular deployment, with microreactors forming a further, smaller subcategory typically at or below about 20 MWe¹,². The intellectual property divides across several regions, each a distinct area of patenting: reactor core and fuel design, spanning light-water designs and advanced non-light-water designs using gas, liquid metal, or molten salt as a coolant; passive safety systems, which rely on natural circulation, integral primary-system design, and large coolant inventory per unit of power rather than powered pumps and operator action — a design philosophy explicitly framed in the literature as a direct lesson from prior operating experience³,⁴; factory fabrication and modular-construction methods, the core cost and schedule thesis behind SMRs; and grid, thermal-storage, and data-center integration. Because a deployable SMR project depends on all of these layers, and because reactor types differ fundamentally in coolant and fuel choice, freedom-to-operate and white space analysis must span reactor type and layer together.
Global deployment status is best read from primary trackers such as the IAEA's Advanced Reactors Information System and coordinated European Commission Joint Research Centre analysis, which draws directly on that database to map the SMR ecosystem, rather than from market-research aggregation⁵. Reliable, precise, primary-sourced counts of reactors currently operating, under construction, or in licensing were not confirmed against an authoritative tracker in this research pass, so specific status figures should be verified against ARIS or the equivalent national regulator's own docket before being cited as current. On the fuel side, HALEU (high-assay low-enriched uranium, enriched to roughly 5–20% U-235) is a recognized supply-chain bottleneck for most advanced non-light-water designs; a European Parliament briefing, citing the US program, reports that Centrus Energy produced the first US HALEU in over 70 years under the Department of Energy's HALEU Availability Program, targeting roughly 900 kg per year toward 2030, though this is a secondary (EU) rendering of the US disclosure rather than the DOE's own primary document⁶. Because applications publish about eighteen months after filing, the most recent passive-safety and modular-fabrication filings are under-represented, so the current frontier is more active than granted-patent counts suggest.
The dominant driver of near-term commercial interest is electricity demand from AI data centers, and the clearest primary-sourced example is Google's own announcement of what it described as the first corporate agreement to purchase nuclear energy from multiple SMRs, an order for up to 500 MW of capacity from Kairos Power with a first unit targeted around 2030 — a target date, not a regulator-confirmed operating date⁷,⁸. Other widely cited data-center nuclear commitments from additional technology companies were sourced in this pass from secondary reporting rather than each company's own press release or the relevant utility's regulatory filing, and should be confirmed against those primary sources before being treated as settled. On the economics side, peer-reviewed work provides the methodological backbone for SMR cost analysis, and the recurring finding is that modularity and factory learning are the central economic lever behind SMR cost claims but remain empirically unproven, since no SMR has yet actually been built at commercial scale to validate the factory-learning thesis⁹.
The strategic picture turns on which reactor type and which layer is hardest to design around, and here the patent corpus itself requires a significant caveat. A patent search on the literal term "SMR" is heavily contaminated by an entirely unrelated field that shares the same abbreviation — steam methane reforming, a chemical-reactor process — such that a raw, unfiltered ranking is dominated by petrochemical entities that are not nuclear SMR filers at all. Once filtered to clearly nuclear assignees, the genuine SMR patent landscape is led by reactor developers such as Westinghouse, NuScale, TerraPower, and BWXT, alongside academic and national-institution filers working on molten-salt designs. Passive safety-system IP is widely regarded as the single most technically intensive and contested domain in SMR development, since it is central to both regulatory approval and the reduced-footprint site design that makes SMRs viable near data centers and other non-traditional locations. Beyond safety systems, the white space includes non-light-water reactor types that remain earlier in development and less crowded than light-water SMRs; HALEU fuel supply chain and fabrication IP, a genuine bottleneck across nearly every advanced design; and the thermal and electrical integration systems that couple a reactor to a data center's variable, high-density cooling and power loads. Reading the landscape by reactor type, layer, and owner — after filtering out the steam-methane-reforming noise — and tracking both the patents and the underlying nuclear-engineering research, is what separates a workable deployment position from a blocked one.
Where the small modular reactor white space is
Non-light-water reactor types. Gas-cooled, liquid-metal-cooled, and molten-salt SMR designs are earlier in development and less crowded than light-water designs, offering higher-temperature output and, in some cases, simplified passive safety.
HALEU fuel supply chain and fabrication. High-assay low-enriched uranium fuel is required by most advanced non-light-water designs and remains a genuine, primary-sourced supply-chain bottleneck, making fuel-fabrication and enrichment IP a distinct, high-value layer⁶.
Factory fabrication and modular construction. Methods that close the cost and schedule gap between a first-of-a-kind unit and Nth-of-a-kind serial production are the core economic thesis of SMRs, and peer-reviewed economics literature confirms this thesis remains empirically unvalidated at scale — a genuine open question, not settled fact⁹.
Data-center thermal and electrical integration. Coupling reactor heat-rejection and power output to a data center's variable, high-density cooling and compute loads is an emerging, largely unclaimed layer distinct from conventional grid integration.
Verified project-status tracking. Because primary-sourced operating/under-construction/licensing status is scarce relative to the volume of announcements, and because the patent corpus itself requires filtering against an unrelated identically-named chemical process, a rigorously verified view of the field is itself a differentiator.
How AI-powered landscape and white space analysis helps
Resolving a landscape that spans multiple reactor coolant types, passive safety-system engineering, fuel supply chain, and an entirely new data-center integration layer — while filtering out an unrelated, identically-abbreviated chemical-process field — requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by reactor type and layer while distinguishing nuclear SMR filings from steam-methane-reforming noise, attribution that normalizes reactor-developer, utility, and technology-company filers to canonical entities, and continuous monitoring that keeps pace with a field where licensing milestones and data-center power deals are both moving quickly. Because nuclear-engineering advances appear in scientific and regulatory literature before they translate into patents, reading both patents and literature gives the earliest signal of which reactor type and layer is actually closing the gap to commercial deployment.
The competitive landscape by the numbers
The raw "SMR" patent corpus is dominated by steam methane reforming and general chemical-reactor art rather than nuclear small modular reactors — the top unfiltered assignees include major petrochemical and catalysis companies that have no connection to nuclear technology, and this contamination means raw top-N assignee or geography rankings from an unfiltered query should not be presented as a nuclear SMR landscape (Cypris corpus, indicative; 2025–26 partial). Filtering to clearly nuclear-specific assignees surfaces the genuine SMR reactor-developer landscape led by Westinghouse, NuScale, TerraPower, and BWXT (developer of the mPower design), with academic and national-institution filers active in molten-salt-specific IP (Cypris corpus, indicative; 2025–26 partial). Geography in the filtered nuclear-specific set skews toward China and the United States. A reliable coolant-type and layer-specific split, and a clean total patent-family count, could not be produced from the contaminated raw corpus in this pass and are not presented here as authoritative; a follow-on query built on a nuclear-specific classification filter (rather than the "SMR" keyword alone) is needed to produce a trustworthy count.
Where Cypris fits
Cypris runs patent landscape and white space analysis for fast-deploying energy fields such as small modular reactors across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by reactor type, light-water, gas-cooled, liquid-metal-cooled, and molten-salt, and by layer, core and fuel design, passive safety, factory fabrication, and grid/data-center integration, and normalizes reactor-developer, utility, and technology-company filers to canonical entities — critically, distinguishing genuine nuclear SMR filings from the unrelated steam-methane-reforming field that shares the same abbreviation — so a team can resolve which reactor types and layers are crowded and which remain open as white space. Semantic search across patents and scientific literature connects filings to the underlying nuclear-engineering research, which is where SMR advances appear first. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined reactor type or layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.
FAQ
What is a small modular reactor? A small modular reactor is a nuclear fission unit generally rated at or below roughly 300 MWe (microreactors at or below about 20 MWe), engineered so its major components can be built on an assembly line in a factory and shipped to site rather than constructed piece by piece in place¹,². This factory-first approach is the core cost and schedule thesis behind SMRs, though peer-reviewed economics literature notes it remains empirically unvalidated since no SMR has yet been built at commercial scale⁹. Designs span both light-water and advanced non-light-water coolant types.
Why are small modular reactors a patenting hotspot now? Small modular reactors are a patenting hotspot now because AI data centers' rapidly growing electricity demand has made carbon-free, co-locatable baseload power commercially urgent — Google's own announcement of an order for up to 500 MW from Kairos Power is the clearest primary-sourced example of this trend⁷,⁸. That deployment pressure is driving filings across safety systems, fuel design, and data-center integration.
What layers does the SMR patent landscape cover? The landscape covers reactor core and fuel design, passive safety systems, factory fabrication and modular-construction methods, and grid and data-center integration. Each is a distinct region of patenting held by different developers, utilities, and technology companies. Freedom-to-operate and white space analysis must span reactor type and layer together.
Why is the "SMR" patent corpus hard to search accurately? The "SMR" patent corpus is hard to search accurately because the abbreviation is shared with steam methane reforming, an unrelated chemical process for producing hydrogen, and a raw keyword search returns a corpus dominated by petrochemical and catalysis companies rather than nuclear reactor developers. Filtering to nuclear-specific classification and assignees is required to see the genuine small modular reactor landscape, led by developers such as Westinghouse, NuScale, TerraPower, and BWXT. This is a significant, easy-to-miss data-quality issue in SMR patent analysis.
Why are passive safety systems the most contested layer? Passive safety systems are the most contested layer because they rely on natural circulation and integral primary-system design rather than powered pumps and operator action, a design philosophy explicitly developed as a lesson from prior operating experience³,⁴, and because it is central both to regulatory approval and to the reduced-footprint site design that makes SMRs viable in non-traditional locations such as data-center campuses. It is accordingly one of the most technically intensive and IP-contested domains in SMR development.
Where is the white space in small modular reactors? The white space includes non-light-water reactor types, HALEU fuel supply chain and fabrication, factory fabrication and modular construction methods (an economically unproven thesis worth backing with real data), data-center thermal and electrical integration, and rigorously verified project-status tracking. Light-water SMR designs and core passive-safety concepts are comparatively more developed. The newer reactor types and the data-center integration layer are the most open ground.
Why is HALEU fuel a bottleneck? HALEU, or high-assay low-enriched uranium, is required by most advanced non-light-water SMR designs, and while the US has begun domestic production under the DOE's HALEU Availability Program, reported capacity remains modest (on the order of 900 kg per year targeted toward 2030) relative to the number of designs that depend on it⁶. This makes fuel supply chain and fabrication IP a distinct, high-value layer independent of reactor design itself.
Why does SMR analysis need scientific literature? SMR analysis needs scientific literature because reactor-physics, fuel, and passive-safety advances appear in nuclear-engineering research and regulatory technical literature before they are patented, and because much of the public narrative around SMR deployment status and data-center deals outruns what is confirmed in primary regulatory or company disclosures. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.
Which teams use small modular reactor patent landscape analysis? Small modular reactor patent landscape analysis is used by R&D, IP, and strategy teams at reactor developers, utilities, and data-center and technology companies exploring co-located nuclear power, as well as investors and policymakers. Because the landscape spans multiple reactor types at different licensing and deployment stages, and because raw keyword search is contaminated by an unrelated chemical-process field, structured analysis is essential. Cypris serves hundreds of enterprise customers across energy and other research-intensive industries.
Endnotes
- Friedman E. Small Modular Reactors (SMRs). Oxford University Press eBooks. DOI: 10.1093/9780198925811.003.0023.
- Sinha V. Small Modular Reactors (SMRs) and Microreactors: Understanding the Major Designs Shaping the Future of Nuclear Energy. Zenodo. DOI: 10.5281/zenodo.20710566.
- Ingersoll DT. Passive Safety Features for Small Modular Reactors. World Scientific eBooks. DOI: 10.1142/9789814365932_0012.
- Ilyas M, Aydoğan F, Butt HN, Ahmad M. Assessment of passive safety system of a Small Modular Reactor (SMR). Annals of Nuclear Energy. DOI: 10.1016/j.anucene.2016.07.018.
- European Commission Joint Research Centre. An exploratory analysis of the Small Modular Reactor ecosystem (drawing on IAEA ARIS). publications.jrc.ec.europa.eu.
- European Parliament Research Service (EPRS). Strategic autonomy and the future of nuclear energy in the EU, citing the US DOE HALEU Availability Program and Centrus Energy production. europarl.europa.eu.
- Google. Google signs advanced nuclear clean energy agreement with Kairos Power. Company blog announcement, October 2024.
- Kairos Power. Google and Kairos Power Partner to Deploy 500 MW of Clean Electricity Generation. Company press release.
- Locatelli G, Mignacca B. Economics and finance of Small Modular Reactors: A systematic review and research agenda. Renewable and Sustainable Energy Reviews. DOI: 10.1016/j.rser.2019.109519.
- Cypris platform corpus analysis, small modular reactor patent families (nuclear-filtered where noted). Indicative figures; 2025–2026 partial.
.avif)
